John N. Kapoor

John N. Kapoor is a declared insider at 6 companies; the most frequent names are Akorn Inc, Neopharm Inc and Insys Therapeutics, Inc. In total, 115 filings cover trades dated from 5 January 2006 to 25 January 2018.

Market trades split into 35 purchases (€4.1M) and 20 sales (€128.6M). On balance, insiders were net sellers of €124.5M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 27 share grants and 7 option exercises. So far in 2018, the count stands at no purchases and 1 sale.

In size, the median ticket on the buying side is €27k.

On 26 January 2018 came the latest disclosure, an option exercise for €215k in Akorn Inc. The clock since the last published purchase (10 March 2015) now reads 4,246 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.